Advertisement
Advertisement

LMRI

L

Lumexa Imaging Holdings, Inc. Common Stock

12.19
USD
Sponsored
-0.51
-4.01%
Mar 13, 16:00 UTC -4
Closed
exchange

Pre-Market

11.39

-0.80
-6.55%

LMRI Earnings Reports

Positive Surprise Ratio

No Data Available for LMRI

0%

Next Report

Date of Next Report
Mar 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$266.43M
/
$0.07
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

Lumexa Imaging Holdings, Inc. Common Stock earnings per share and revenue

On --, LMRI reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of 0.07 USD, with revenue projected to reach 266.43 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.14
Surprise
+6.63%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
Viemed Healthcare, Inc. Common Shares
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+10.85%
logo
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
logo
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
logo
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
logo
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
logo
Immucell Corp
Report Date
Mar 04, 2026 For Q4 25
Estimate
-
Actual
-$0.31
Surprise
-
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
For Q-- --, Lumexa Imaging Holdings, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Mar 26, 2026.
Based on -- analysts, Lumexa Imaging Holdings, Inc. Common Stock is expected to report EPS of $0.07 and revenue of $266.43M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement